Navigation Links
Parent Project Muscular Dystrophy Awards $750,000 Grant to Sildenafil/Taladafil Study
Date:4/4/2011

HACKENSACK, N.J., April 4, 2011 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD) – the largest, most comprehensive  non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne) – announced today that they will award Ronald G. Victor, M.D. of Cedars-Sinai Medical Center, a $750,000 grant to fund his study of phosphodiesterase inhibitors (sildenafil and taladafil) as a possible therapy for Duchenne.

(Logo: http://photos.prnewswire.com/prnh/20100119/DC39975LOGO)

Dr. Victor and his team at the Cedars-Sinai Heart Institute in Los Angeles discovered a defect in muscle blood flow in mdx mice and boys with Duchenne. Correcting this defect with phosphodiesterase inhibitors (sildenafil and taladafil) improves muscle and heart function in mdx mice. Dr. Victor will conduct a clinical research study to determine if these drugs can improve muscle blood flow in boys with Duchenne, with plans to continue on to a larger multi-center clinical outcomes trial examining both heart and muscle function.

PPMD President and CEO Pat Furlong said that the organization is pleased to support the work of Dr. Victor and Cedars-Sinai. "Parent Project Muscular Dystrophy launched a cardiac initiative at the beginning of this year so that potential treatments in Duchenne took into consideration the effect therapies may have on the heart. Dr. Victor and the wonderful people at Cedars-Sinai have not only taken into consideration cardiac issues in Duchenne, but are also combining existing FDA approved drugs for use as a potential therapy. We are excited by the potential benefit of Dr. Victor's work with sildenafil and taladafil, and continue to be grateful that leading institutions around the country, like Cedars-Sinai Medical Center, are working with this community to end Duchenne."

Dr. Victor, who serves as Associate Director of Clinical Research, Director of the Hypertension Center, and Burns and Allen Professor of Medicine at the Cedars-Sinai Heart Institute, said he was excited that his research team had been awarded the $750,000 grant from Parent Project Muscular Dystrophy.

"To work on a project you feel so passionately about for a community you feel so passionately about, is a reward in and of itself," Dr. Victor said.  "But to have an organization as well respected and trusted at an international level, like Parent Project Muscular Dystrophy, to support your work with such a substantial grant is truly overwhelming. I am so grateful to Pat Furlong for the contribution she continues to make to Duchenne research by supporting projects like mine. She inspires the people in our lab to work even harder to find a therapy that will stop the progression of this devastating disorder."  

Ms. Furlong explained that PPMD has a long history of supporting promising therapies and taking risk on research strategies that otherwise might not get the financial backing they need. "The parents that make up the Duchenne community all share one single goal, to end Duchenne. We take our responsibility to our families very seriously: to thoroughly vet and financially support any research project, any therapy that brings us one step closer to this goal. When we announce something like the cardiac initiative that we launched earlier this year, we put our money where our mouth is. This grant to Dr. Victor combined with our recent $250,000 grant to PTC Therapeutics, gives us a total research investment of $1 million in the first quarter of 2011. We will continue to fund hope for young men living with Duchenne, whenever the opportunity presents itself."

For more about Parent Project Muscular Dystrophy's grant program, as well as a comprehensive list of what we are funding, please visit ParentProjectMD.org/Research.

About Duchenne muscular dystrophy

Duchenne, the most common form of childhood muscular dystrophy, is a progressive and fatal muscle disorder affecting boys and young men that causes the loss of muscle function, wheelchair dependency and a decline in respiratory and cardiac function.  

About Parent Project Muscular Dystrophy

Parent Project Muscular Dystrophy (PPMD) is a national not-for-profit organization founded in 1994 by parents of children with Duchenne and Becker muscular dystrophy.  Our mission is to end Duchenne. We accelerate research, raise our voices in Washington, demand optimal care for all young men, and educate the global community. PPMD is headquartered in Middletown, Ohio with offices in Fort Lee, New Jersey.  For more information, visit www.parentprojectmd.org.


'/>"/>
SOURCE Parent Project Muscular Dystrophy
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Book From Siren Interactive Reveals How Parents of Children With Rare Diseases Play Major Roles in Diagnosis and Treatment
2. Parents Continue to Give Cough and Cold Meds to Young Kids, Despite FDA Warnings
3. Parents, Physicians Unite and Declare: State of Emergency
4. PTC Therapeutics and Parent Project Muscular Dystrophy Advance Drug Discovery Program to Improve Heart Function in Duchenne/Becker Muscular Dystrophy Patients
5. State Launches Immunize for Good Marketing Campaign to Remind Parents Immunizations are Safe and the Best Way to Prevent Childhood Illness
6. Med Time Technology, Inc. Teams up with Give A Smile, Inc. to Provide Pill Timer™ Kits and Toys to Children and Parents at the Chris Evert Childrens Hospital of Broward General
7. Parents Bring Federal Lawsuit After Tainted Baby Formula Injures Newborn
8. Vaccine and Medication Safety are Parents Top Research Priorities
9. New Hope in Austin, Texas for Children Dealing with Social, Academic and Behavioral Issues; Austin Brain Balance Achievement Centers Grand Opening to Include Lectures for Parents, Teachers and Health Professionals
10. Formation of Contract Parenteral Drug Development Services Company Announced
11. Gold Standard/Elsevier Offers Timely, Transparent, Reliable Drug Pricing Data, Including Average Wholesale Price (AWP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
(Date:6/24/2016)... 2016   Bay Area Lyme Foundation , ... Center for Tick Borne Illness , Harvard Medical ... Hacking Medicine, University of California, Berkeley, and the ... five finalists of Lyme Innovation , the ... 100 scientists, clinicians, researchers, entrepreneurs, and investors from ...
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
Breaking Medicine Technology:
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):